protein kinase C nu

01/01/2020 - "Previous study suggested that Protein Kinase D3 (PRKD3) was involved in breast cancer progression. "
01/01/2020 - "Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer."
01/01/2017 - "Protein Kinase D3 (PRKD3) functions as an important oncogenic driver in invasive breast cancer, which is the leading cause of women mortality. "
01/01/2017 - "Oncogenic Protein Kinase D3 Regulating Networks in Invasive Breast Cancer."

02/01/2021 - "Here, protein kinase D3 (PRKD3) is defined to be a key regulator of CLU in promoting TNBC tumor growth. "
01/01/2021 - "The oncogenic role of protein kinase D3 in cancer."
11/01/2021 - "Protein kinase D3 (PKD3) has been involved in various aspects of tumorigenesis and progression in many kinds of cancer types. "
07/01/2012 - "Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer."
02/01/2021 - "Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple-Negative Breast Cancer Tumor Growth."

01/01/2023 - "Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration."
10/15/2012 - "Although protein kinase D3 (PKD3) has been shown to contribute to prostate cancer cell growth and survival, the role of PKD in prostate cancer cell motility remains unclear. "
08/01/2010 - "[Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells]."
05/15/2008 - "Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2."
07/01/2012 - "Inducible silencing of protein kinase D3 inhibits secretion of tumor-promoting factors in prostate cancer."

02/07/2014 - "Elevated protein kinase D3 (PKD3) expression supports proliferation of triple-negative breast cancer cells and contributes to mTORC1-S6K1 pathway activation."
01/01/2020 - "Protein kinase D3 (PKD3) is upregulated in triple-negative breast cancer (TNBC) and associated with cell proliferation and metastasis development but its precise pro-oncogenic function is unknown. "
02/07/2014 - "Here, we show that the expression of the Golgi-localized serine-threonine kinase protein kinase D3 (PKD3) is elevated in triple-negative breast cancer (TNBC). "
02/01/2021 - "Inhibition Lysosomal Degradation of Clusterin by Protein Kinase D3 Promotes Triple-Negative Breast Cancer Tumor Growth."

10/01/2011 - "Protein kinase D3 is the genetic sensitizer of RAF inhibitor RAF265 in melanoma cells."
06/15/2011 - "Protein kinase D3 sensitizes RAF inhibitor RAF265 in melanoma cells by preventing reactivation of MAPK signaling."
06/15/2011 - "In this way, we found that knockdown of protein kinase D3 (PRKD3) could enhance cell killing of RAF and MEK inhibitors across multiple melanoma cell lines of various genotypes and sensitivities to RAF265. "